SmartVest for Mucus Clearance Can Reduce Healthcare Use, Costs for Bronchiectasis Patients

SmartVest for Mucus Clearance Can Reduce Healthcare Use, Costs for Bronchiectasis Patients
The use of Electromed’s SmartVest Airway Clearance System can reduce healthcare use and costs for patients with bronchiectacis, according to a new study. Results indicated that SmartVest may help save patients as much as $3,045 per year of use. The study, “Cost-Effective Analysis Of Using High Frequency Chest Wall Oscillation (HFCWO) In Patients With Non-Cystic Fibrosis Bronchiectasis,” was published in the journal Respiratory Therapy: The Journal of Pulmonary Technique. According to the authors, the annual medical cost of care for U.S. bronchiectasis patients in 2001 was $13,244 per patient, which was greater than the annual cost for many other chronic diseases, such as heart disease ($12,000) and chronic obstructive pulmonary disease (COPD; $11,000). Also, a study from 2005 showed that bronchiectasis patients spent on average two more days per year in the hospital, had around six additional outpatient encounters, and 27.2 more days of antibiotic treatment, compared to patients without the disease. In the same year, the annual cost for bronchiectasis care reached $630 million. Bronchiectasis treatments include high frequency chest wall oscillation (HFCWO), a method that delivers compression pulses to the chest wall within a range of selectable frequencies. These devices promote the release of mucus from the lung’s wall, helping eliminate it from the body and cleari
Subscribe or log in to read the rest of this content.